156817-68-4

Basic information

• Product Name: Imidazo[1,2-a]pyridin-8-ol, 5,6,7,8-tetrahydro- (9CI)
• Synonyms: Imidazo[1,2-a]pyridin-8-ol, 5,6,7,8-tetrahydro- (9CI)
• CAS NO: 156817-68-4
• Molecular Formula: C7H10N2O
• Molecular Weight: 138.1671
• Product Categories: AMINETERTIARY
• Mol File: 156817-68-4.mol

Chemical Properties

• Boiling Point: 365.0±25.0 °C(Predicted)
• Appearance: /
• Density: 1.37±0.1 g/cm3(Predicted)
• PKA: 13.48±0.20(Predicted)
• CAS DataBase Reference: Imidazo[1,2-a]pyridin-8-ol, 5,6,7,8-tetrahydro- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,2-a]pyridin-8-ol, 5,6,7,8-tetrahydro- (9CI)(156817-68-4)
• EPA Substance Registry System: Imidazo[1,2-a]pyridin-8-ol, 5,6,7,8-tetrahydro- (9CI)(156817-68-4)

Safety Data

• Hazardous Substances Data: 156817-68-4(Hazardous Substances Data)

Upstream product

• 645-36-3 2,2-diethoxy-ethanamine 
• 19365-08-3 3-hydroxypiperidin-2-one 
• 96428-16-9 8-(phenylmethoxy)imidazo[1,2-a]pyridine 
• 16867-03-1 2-amino-3-hydroxypyridine 
• 24016-03-3 2-amino-3-benzyloxypyridine 

Downstream Products

• 457949-09-6 6,7-dihydroimidazo[1,2-a]pyridine-8(5H)-one 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING

Provided herein are compounds having activity against TTR related conditions, and pharmaceutically accepted salts and solvates thereof. Also provided are methods of using the compounds for inhibiting and preventing TTR aggregation and/or amyloid formation in the peripheral nerves, kidney, cardiac tissue, eye and CNS, and of treating a subject with peripheral TTR amyloidosis.

Bisheterocycle substituted oxa-spiro derivative, and preparation method and medical application thereof

The invention relates to a bisheterocyclic substituted oxa-spiro derivative, and a preparation method and medical application thereof. Specifically, the invention discloses compounds of formula (I) and formula (II) or pharmaceutically acceptable salts, stereoisomers or solvates thereof, and a preparation method and application thereof. Each group in the formulas is as defined in the specificationand claims in detail.

Multi-substituted amine compound and its preparation and use (by machine translation)

The invention belongs to the field of medical technology, in particular, the present invention provides the following formula I shown multi-substituted amine compound or its isomer or its pharmaceutically acceptable salt, ester, prodrug or hydrate, its pharmaceutical composition, preparation method thereof and its use in the preparation of medicine for treating aids in use. The compound or pharmaceutical composition containing the compound can be used as an inhibitor for inhibiting HIV integrase with LEDGF/p75 between protein - protein interaction and HIV integrase dimerization, then can be used for the treatment of aids. . (by machine translation)

COMPOUND, COMPOSITIONS, AND METHODS

Compounds having activity as LRRK2 inhibitors are disclosed. The compounds are of formula (I) including stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.